SOLUTION NMR

NMR Experiment
Experiment Type Sample Contents Ionic Strength Solvent pH Pressure Temprature (K)
1 2D 1H-13C HSQC 0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS, 90% H2O/10% D2O 10 90% H2O/10% D2O 6.8 AMBIENT 298
2 2D 1H-15N HSQC 0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS, 90% H2O/10% D2O 10 90% H2O/10% D2O 6.8 AMBIENT 298
3 3D 1H-15N NOESY 0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS, 90% H2O/10% D2O 10 90% H2O/10% D2O 6.8 AMBIENT 298
4 3D 1H-13C NOESY aliphatic 0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS, 90% H2O/10% D2O 10 90% H2O/10% D2O 6.8 AMBIENT 298
5 3D 1H-13C NOESY aromatic 0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS, 90% H2O/10% D2O 10 90% H2O/10% D2O 6.8 AMBIENT 298
6 3D H(CCO)NH 0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS, 90% H2O/10% D2O 10 90% H2O/10% D2O 6.8 AMBIENT 298
7 3D HNCO 0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS, 90% H2O/10% D2O 10 90% H2O/10% D2O 6.8 AMBIENT 298
8 3D HN(CO)CA 0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS, 90% H2O/10% D2O 10 90% H2O/10% D2O 6.8 AMBIENT 298
9 3D CBCA(CO)NH 0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS, 90% H2O/10% D2O 10 90% H2O/10% D2O 6.8 AMBIENT 298
10 3D HNCA 0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS, 90% H2O/10% D2O 10 90% H2O/10% D2O 6.8 AMBIENT 298
NMR Spectrometer Information
Spectrometer Manufacturer Model Field Strength
1 Bruker AVANCE NEO 800
NMR Refinement
Method Details Software
torsion angle dynamics ? 4
NMR Ensemble Information
Conformer Selection Criteria target function
Conformers Calculated Total Number 100
Conformers Submitted Total Number 20
Representative Model 1 (lowest energy)
Computation: NMR Software
# Classification Version Software Name Author
1 collection 4.1.2 TopSpin Bruker Biospin
2 chemical shift assignment 3.190 NMRFAM-SPARKY Lee, W.; Tonelli, M.; Markley, J. L. NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics 2015, 31 (8), 1325-1327. DOI: 10.1093/bioinformatics/btu830.
3 structure calculation 3.98.13 CYANA Guntert, Mumenthaler and Wuthrich
4 refinement ? PROCHECK / PROCHECK-NMR Laskowski, MacArthur, Smith, Jones, Hutchinson, Morris, Moss and Thornton
Feedback Form
Name
Email
Institute
Feedback